U.S. Global Investors to Restate Q3 EPS; Core Financials Unaffected
GROW sits 18% above its 52-week low of $2.2 on elevated volume (2.0× avg).
Summary
U.S. Global Investors announced its intent to restate earnings per share (EPS) for its March 31, 2026, financial statements. This relates to the third-quarter results that were reported as robust on May 13th. Crucially, the company stated that the underlying financial results, such as revenue and net income, remain unchanged. While the core business performance is not impacted, any restatement indicates an accounting or reporting issue, which can raise concerns about financial controls and transparency.
At the time of this announcement, GROW was trading at $2.59 on NASDAQ in the Finance sector, with a market capitalization of approximately $26.8M. The 52-week trading range was $2.20 to $3.65. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.